Email this article INFECTIOUS COMPLICATIONS IN PATIENTS WITH LUNG CANCER
- Authors: Grigoryevskaya Z.V.1
-
Affiliations:
- N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences
- Issue: Vol 5, No 1 (2011)
- Pages: 9-13
- Section: REVIEW
- Published: 15.01.2011
- URL: https://klinitsist.abvpress.ru/Klin/article/view/130
- DOI: https://doi.org/10.17650/1818-8338-2011-1-9-13
- ID: 130
Cite item
Full Text
Abstract
Lung cancer (LC) annually afflicts 63–65 thousand people in Russia and 1.04 million worldwide, which amounts to 12.8% of all notified cases of neoplasms. In LC patients, infectious complications are characterized by a severe course; destruction foci, decay cavities, and abscess may form.
All give rise to difficulties in making a diagnosis and in choosing a treatment policy. Infections caused by P. aeruginosa, A. baumanii, bacteria of the family Enterobacteriacae, S. aureus, and Enterococcus spp present the greatest problem in inpatients with LC. The early diagnosis of infectious
complications and the use of adequate schemes of antibiotic prevention and therapy promote a reduction in mortality from infection in this category
of patients and expand the possibilities of their specific antitumor treatment.
About the authors
Z. V. Grigoryevskaya
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences
Author for correspondence.
Email: zlatadoc@list.ru
Laboratory of Microbiological Diagnosis and Treatment of Infections in Oncological Care Russian Federation
References
Supplementary files
